4baseCare Secures ₹90 Crore to Propel AI-Powered Cancer Care Expansion

• Bengaluru-based 4baseCare, a precision oncology startup, raised ₹90 crore in its Series B round, co-led by Ashish Kacholia and Lashit Sanghvi.
• The funding will expand its hospital-linked lab network, strengthen its AI-driven oncology platform (Oncotwin), and accelerate international market penetration.
• Oncotwin, the world's first oncology digital twin platform, simulates patient-specific cancer outcomes and has been selected by Memorial Sloan Kettering Cancer Center for validation.
• 4baseCare aims to address the global cancer data diversity gap, focusing on population-specific genomic intelligence for Indian and similar patient cohorts.
• The company plans to establish 25 new lab collaborations within 12-18 months (70% in India, 30% internationally) and targets ₹100 crore revenue in the next 12-18 months.